Patents by Inventor Candice B. Biggs

Candice B. Biggs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4345030
    Abstract: Mutant which is used in a novel microbiological process to selectively degrade steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to yield predominantly androst-4-ene-3,17-dione (AD) and small amounts of androsta-1,4-diene-3,17-dione (ADD). AD is a valuable intermediate to make useful steroids.
    Type: Grant
    Filed: September 8, 1980
    Date of Patent: August 17, 1982
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Candice B. Biggs
  • Patent number: 4345033
    Abstract: Mutant which is used in a novel microbiological process to selectively degrade steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to yield predominantly androst-4-ene-3,17-dione (AD) and small amounts of androsta-1,4-diene-3,17-dione (ADD). AD is a valuable intermediate to make useful steroids.
    Type: Grant
    Filed: September 8, 1980
    Date of Patent: August 17, 1982
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Candice B. Biggs, Thomas R. Pyke
  • Patent number: 4345029
    Abstract: Mutants which are used in a novel microbiological process to selectively degrade steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to androsta-1,4-diene-3,17-dione (ADD) and androst-4-ene-3,17-dione (AD). ADD and AD are valuable intermediates to make useful steroids.
    Type: Grant
    Filed: September 8, 1980
    Date of Patent: August 17, 1982
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Candice B. Biggs
  • Patent number: 4339539
    Abstract: Mutants which are used in a novel microbiological process to selectively degrade steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to androsta-1,4-diene-3,17-dione (ADD) and androst-4-ene-3,17-dione (AD). ADD and AD are valuable intermediates to make useful steroids.
    Type: Grant
    Filed: September 8, 1980
    Date of Patent: July 13, 1982
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Candice B. Biggs, Thomas R. Pyke
  • Patent number: 4328315
    Abstract: Mutants which are used in a novel microbiological process to selectively degrade steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to androsta-1,4-diene-3,17-dione (ADD) and androst-4-ene-3,17-dione (AD). ADD and AD are valuable intermediates to make useful steroids.
    Type: Grant
    Filed: September 8, 1980
    Date of Patent: May 4, 1982
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Candice B. Biggs, Thomas R. Pyke
  • Patent number: 4293644
    Abstract: Mutant which is used in a novel microbiological process to selectively degrade steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to yield predominantly androst-4-ene-3,17-dione (AD) and small amounts of androsta-1,4-diene-3,17-dione (ADD). AD is a valuable intermediate to make useful steroids.
    Type: Grant
    Filed: October 9, 1977
    Date of Patent: October 6, 1981
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Candice B. Biggs
  • Patent number: 4293645
    Abstract: Mutants which are used in a novel microbiological process to selectively degrade steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to androsta-1,4-diene-3,17-dione (ADD) and androst-4-ene-3,17-dione (AD). ADD and AD are valuable intermediates to make useful steroids.
    Type: Grant
    Filed: November 9, 1977
    Date of Patent: October 6, 1981
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Candice B. Biggs, Thomas R. Pyke
  • Patent number: 4211841
    Abstract: Novel microbial transformation process to selectively convert steroids with or without 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to 3a.alpha.-H-4.alpha.-[3'-propionic acid]-7a.beta.-methylhexahydro-1,5-indanedione having the following structure: ##STR1## This compound can be used as an intermediate to make useful 19-nor steroids.
    Type: Grant
    Filed: November 20, 1978
    Date of Patent: July 8, 1980
    Assignee: The Upjohn Company
    Inventors: Candice B. Biggs, Thomas R. Pyke, Merle G. Wovcha
  • Patent number: 4062729
    Abstract: Novel microbial transformation process to selectively convert steroids with or without 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to 3a.alpha.-H-4.alpha.-[3'-propionic acid]-7a.beta.-methylhexahydro-1,5-indanedione having the following structure: ##STR1## This compound can be used as an intermediate to make useful 19-nor steroids.
    Type: Grant
    Filed: November 26, 1976
    Date of Patent: December 13, 1977
    Assignee: The Upjohn Company
    Inventors: Candice B. Biggs, Thomas R. Pyke, Merle G. Wovcha